Medtech InsightDeals In September BI, Inflammasome Ally In $160m Retinal Diseases Collaboration Boehringer Ingelheim International GmbH and Inflammasome Therapeutics Inc. agreed to co-develop up to three candida
ScripWith an eye on the rising number of tech-savvy patients and health care personnel (HCP) relying on digital information, Lupin Ltd. has partnered with Aptar Pharma to introduce India’s first smart
ScripDerived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma
Pink SheetOn the heels of Amgen Inc. and Allergan PLC launching the first two oncology biosimilars in the US, the US Food and Drug Administration approved a pair of new biosimilars just days later: Pfizer